H. Nagasaki et al., 2 NOVEL MUTATIONS IN THE CODING REGION FOR NEUROPHYSIN-II ASSOCIATED WITH FAMILIAL CENTRAL DIABETES-INSIPIDUS, The Journal of clinical endocrinology and metabolism, 80(4), 1995, pp. 1352-1356
Familial central diabetes insipidus is an autosomal dominant disease c
aused by a deficiency of arginine vasopressin (AVP). We previously rep
orted three distinct mutations in the AVP gene in Japanese familial ce
ntral diabetes insipidus pedigrees that result in a substitution of Se
r for Gly(57) in the neurophysin-II (NPII) moiety of the AVP precursor
, a substitution of Thr for Ala at the COOH-terminus of the signal pep
tide, and a deletion of Glu(47) in the NPII moiety. In this study, we
analyzed the AVP gene in two pedigrees by direct sequencing of the pol
ymerase chain reaction-amplified DNA and found two novel mutations in
exon 2, which encodes the central part of the NPII moiety of the precu
rsor. The mutation in one pedigree was a C to A transition at nucleoti
de position 1891, which replaces Cys(67) (TGC) with stop codon (TGA).
As the premature termination eliminates part of the COOH domain of the
NPII moiety and the glycoprotein moiety, the conformation of the trun
cated protein is likely to be markedly different from that of normal p
recursor. In another pedigree, a G to T transversion was detected at n
ucleotide position 1874, which substitutes polar Trp (TGG) for hydroph
obic Gly(62) (GGG). It is possible that mutated NPII molecules, as a c
onsequence of a conformational change, cannot bind AVP or self-associa
te to form higher oligomer complexes. Interestingly, all mutations we
have identified to date, with the exception of the signal peptide muta
tion, are located in exon 2, suggesting the importance of the highly c
onserved central part of the NPII molecules and/or the NPII moiety in
the precursor for AVP synthesis.